Leptospirosis in Dogs: Clinical Diagnosis, Serovar Epidemiology, and Vaccination Strategies

Introduction

Leptospirosis is a globally distributed zoonotic disease caused by pathogenic spirochetes of the genus Leptospira. In domestic dogs, infection results in a spectrum of clinical outcomes ranging from subclinical seroconversion to acute fatal hepatorenal failure. The disease is maintained in the environment by wildlife reservoir hosts that shed leptospires in urine, and dogs acquire infection through contact with contaminated water, soil, or direct exposure to infected animals [2, 6]. Epidemiological studies have demonstrated that meteorological factors such as rainfall and temperature significantly influence the transmission dynamics of leptospirosis in canine populations [2]. The importance of accurate diagnosis, serovar surveillance, and rational vaccination cannot be overstated in both clinical and public health contexts.

This article provides a detailed review of the clinical diagnosis, serovar epidemiology, and vaccination strategies for canine leptospirosis, with emphasis on molecular and serological methods, regional serovar distribution, and evidence-based vaccine recommendations.

Clinical Diagnosis

Pathogenesis and Clinical Signs

Following penetration of mucous membranes or abraded skin, Leptospira organisms enter the bloodstream and produce a leptospiremic phase characterized by fever, lethargy, and myalgia. The spirochetes subsequently colonize the renal tubules and hepatic parenchyma, leading to acute kidney injury (AKI) and cholestatic hepatitis. Clinical signs include polyuria, polydipsia, vomiting, diarrhea, icterus, and abdominal pain. Pulmonary involvement has been documented; a serial evaluation of clinical, functional, and structural pulmonary changes in ten dogs with leptospirosis revealed that respiratory compromise can occur even in the absence of overt radiographic abnormalities [1]. Ocular manifestations, including anterior uveitis, have also been reported, although a pilot study in cats found no definitive association between Leptospira species and endogenous uveitis in that species [14].

Laboratory Abnormalities

Routine hematology and serum biochemistry findings include thrombocytopenia, leukocytosis, azotemia, elevated liver enzymes (alanine aminotransferase, alkaline phosphatase), and hyperbilirubinemia. Urinalysis typically reveals proteinuria, hematuria, and granular casts. Novel biomarkers have been investigated; serum sialic acid has been proposed as an inflammatory and infectious biomarker in veterinary medicine, although its specificity for leptospirosis remains under evaluation [4].

Diagnostic Assays

The diagnosis of canine leptospirosis relies on a combination of serological, molecular, and culture-based methods.

Microscopic Agglutination Test (MAT)
The MAT is the reference standard serological assay. It detects agglutinating antibodies (predominantly IgM) against a panel of live or formalin-fixed Leptospira serovars. A single titer of 1:800 or higher, or a fourfold rise in paired acute and convalescent samples, is considered indicative of current or recent infection. The MAT has limitations, including the need for maintaining live antigen cultures, subjective endpoint reading, and cross-reactivity among serogroups. Despite these drawbacks, it remains widely used in epidemiological studies [7, 13].

Polymerase Chain Reaction (PCR)
PCR assays target conserved genes such as rrs (16S rRNA), secY, or lipL32 and can detect leptospiral DNA in blood, urine, or tissue samples. Real-time quantitative PCR (qPCR) provides rapid, sensitive, and specific confirmation of acute infection, particularly during the leptospiremic phase. Molecular surveillance studies have used PCR to determine the prevalence of Leptospira infection in domestic dog populations [11]. PCR is especially valuable when serological results are inconclusive or when antibiotic therapy has been initiated.

Culture
Isolation of Leptospira from blood, urine, or kidney tissue using specialized media (e.g., Ellinghausen-McCullough-Johnson-Harris medium) is the gold standard for definitive diagnosis but requires prolonged incubation (up to 13 weeks) and is impractical for routine clinical use. Culture remains important for serovar identification and genomic characterization [10].

Lateral Flow Assays
Recombinant antigen-based lateral flow assays have been developed for rapid serodiagnosis. A recent evaluation using a recombinant Loa22-gold nanoparticle lateral flow assay demonstrated promising sensitivity and specificity for detection of anti-leptospiral antibodies in canine serum [12]. Such assays may facilitate point-of-care testing, but further validation is required.

Other Serological Methods
Commercial enzyme-linked immunosorbent assay (ELISA) kits are available for detection of IgM and IgG antibodies. These tests are easier to standardize than MAT but may vary in performance depending on the antigen mixture used. Cross-reactivity with other bacterial infections can occur.

Diagnostic Algorithm

The following decision tree integrates serology and PCR for clinical diagnosis of leptospirosis in dogs.

flowchart TD
    A[Clinical suspicion: fever, azotemia, icterus, thrombocytopenia], > B[Collect blood and urine]
    B, > C{Acute phase <7 days?}
    C, Yes, > D[PCR on blood and urine]
    C, No, > E[MAT on paired sera]
    D, > F{Result?}
    F, Positive, > G[Confirmed leptospirosis]
    F, Negative, > E
    E, > H{Fourfold rise in titer?}
    H, Yes, > G
    H, No, > I[Consider other diagnoses or convalescent retest]
    G, > J[Initiate antibiotic therapy<br/>Supportive care<br/>Notify owner of zoonotic risk]

Table 1 summarizes the strengths and limitations of each diagnostic modality.

Table 1. Comparison of Diagnostic Methods for Canine Leptospirosis

Serovar Epidemiology

Geographic Distribution and Host Adaptation

Leptospiral serovars are defined by agglutinating antibodies against specific lipopolysaccharide (LPS) antigens. The distribution of serovars in canine populations varies geographically and temporally. Historically, serovars Canicola and Icterohaemorrhagiae were dominant in dog populations, reflecting adaptation to canine and rodent hosts, respectively. In recent decades, serovars Grippotyphosa, Pomona, and Bratislava have emerged as important causes of canine disease in North America and Europe.

A genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild animals in Japan revealed evidence of cross-species transmission and host adaptation at the molecular level [10]. An outbreak investigation in Los Angeles County, USA, in 2021 characterized the clinical and molecular features of canine leptospirosis, identifying serogroup Australis as a prominent cause [3]. In the Yangtze River region of China, seroprevalence and molecular epidemiology studies have demonstrated a high prevalence of antibodies to serogroups Australis and Autumnalis in domestic dogs [13].

In tropical and subtropical regions, serovar diversity is generally higher. A serological survey of domiciled and stray dogs in subtropical Mexico found seroprevalence rates exceeding 50% with predominant serovars Canicola and Icterohaemorrhagiae [15]. In Colombia, molecular surveillance in domestic dogs identified pathogenic Leptospira species with a predominance of serogroups Sejroe and Ballum [11]. Similarly, a study from a Fulni-ô Indigenous community in Brazil reported seroprevalence of Leptospira spp. in dogs, underscoring the One Health context of transmission [7]. In Thailand, pathogenic Leptospira species were identified in dogs and cats during neutering campaigns, indicating that intact male dogs may serve as asymptomatic shedders [9].

Risk Factors and Transmission Dynamics

Contact with known canine leptospirosis cases significantly increases the risk of infection in susceptible dogs [8]. Meteorological factors such as heavy rainfall and flooding facilitate environmental persistence and human and animal contact [2]. A systematic review and meta-analysis of canine leptospirosis in China identified male sex, adult age, outdoor access, and presence of rodents as significant risk factors [6].

The role of wild and feral animals as reservoirs is critical. Comparative genomic analysis in Japan showed that isolates from dogs and wild animals (raccoons, wild boar) clustered closely, suggesting bidirectional transmission [10]. In bovine farms, a One Health approach demonstrated leptospiral interaction between cattle, dogs, and the environment [5].

Serovar Distribution Data

Table 2 presents a summary of common serovars and their associated geographic regions.

Table 2. Common Leptospiral Serovars in Dogs by Geographic Region

Vaccination Strategies

Vaccine Types and Composition

Commercially available vaccines for dogs are generally bacterins of inactivated whole-cell Leptospira serovars. Bivalent vaccines contain serovars Canicola and Icterohaemorrhagiae; quadrivalent vaccines include Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona. More recently, vaccines incorporating serovars Australis and Autumnalis have been developed in certain regions to address shifting serovar prevalence.

Bacterin-based vaccines stimulate humoral immunity against LPS antigens but provide limited cross-protection against heterologous serovars. They require an initial two-dose series followed by annual boosters. Adverse reactions, including type I hypersensitivity, are uncommon but recognized.

Efficacy and Duration of Immunity

Vaccination reduces the severity of disease but does not prevent renal colonization or urinary shedding in all animals. An outbreak investigation in Los Angeles County found that some vaccinated dogs still became infected, emphasizing the need for serovar-matched vaccination and continued vigilance [3]. Duration of immunity is typically considered to be one year for most leptospirosis vaccines, though some products claim extended protection for 12 months after the booster series.

Vaccine Recommendations

The World Small Animal Veterinary Association (WSAVA) and many national veterinary associations classify leptospirosis as a core vaccine for dogs in endemic areas or those with lifestyle risk factors. The initial protocol involves two doses administered 2-4 weeks apart, followed by an annual booster. Dogs at high risk (hunting dogs, dogs with outdoor access, dogs in kennels) should be prioritized. Revaccination every six months may be considered in very high-risk environments, although this practice is not universally endorsed.

Owner-Oriented Prevention Tips

Veterinarians should educate pet owners on the following preventive measures.

• Restrict access to stagnant water, ponds, and flooded areas.
• Control rodent populations around the home.
• Leash walk dogs in urban and suburban environments to avoid contact with wildlife urine.
• Clean and disinfect kennel areas with bleach-based solutions.
• Maintain an up-to-date vaccination schedule.
• Seek veterinary attention promptly if fever, lethargy, vomiting, or icterus develop.
• Practice hand hygiene after handling dogs, especially those with suspected leptospirosis.

For a broader discussion of One Health approaches to leptospirosis and other zoonoses, readers are referred to the Hantaviruses in Rodents article on this portal.

Future Directions

Current research is focused on developing recombinant protein or LPS-conjugate vaccines that could provide broader cross-protection. The recombinant Loa22 surface antigen has been evaluated in diagnostic assays and may serve as a component of future vaccine formulations [12]. Genomic comparison studies contribute to our understanding of antigenic diversity and vaccine target selection [10]. Computational modeling of leptospirosis transmission based on diagnostic data may assist in optimizing vaccination strategies at the population level [see the article on Computational Modeling of Veterinary Virus Spread Based on Diagnostic Data].

Conclusions

Canine leptospirosis remains a significant infectious disease with complex diagnostic challenges and shifting serovar epidemiology. Accurate diagnosis requires integration of MAT, PCR, and emerging point-of-care assays. Regional surveillance is essential for guiding vaccine composition and policy. Vaccination, combined with environmental risk management, remains the most effective strategy for reducing disease incidence in dogs and for protecting public health.

References

1. Bringold C, Schweighauser A, Walther S, et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. https://pubmed.ncbi.nlm.nih.gov/42224492/

2. Hobson SJ, Zai B, Vyn CM, et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42211529/

3. Randolph MW, Nally JE, Yoshimoto SK, et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42189535/

4. Yaghoobpour T, Faraji M, Nazifi S. Serum sialic acid as a biomarker of inflammation and infection: Insights from veterinary medicine. Vet Med Int. 2026. https://pubmed.ncbi.nlm.nih.gov/42148179/

5. Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC, et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42090421/

6. Wei W, Jiao D, Dong X, et al. Epidemiology and associated factors of human and canine leptospirosis in China: A systematic review and meta-analysis. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41864068/

7. Galvão CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: A One Health perspective. Braz J Biol. 2026. https://pubmed.ncbi.nlm.nih.gov/41849483/

8. Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/41814781/

9. Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W, et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41637464/

10. Kakita T, Takabe K, Morita M, et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41579465/

11. Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K, et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. https://pubmed.ncbi.nlm.nih.gov/41557245/

12. Gautam H, Kumar BVS, Singh S, et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41524783/

13. Ding Y, Zhang S, Zhang W, et al. Seroprevalence and molecular epidemiology of Leptospira spp. infecting dogs in the Yangtze River region of China. Transbound Emerg Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/41383393/

14. Jost HE, Henriksen ML, Hawley J, et al. Evaluation of Leptospira species as a cause of endogenous uveitis in cats: A pilot study. J Feline Med Surg. 2026. https://pubmed.ncbi.nlm.nih.gov/41378760/

15. Andrade-Silveira E, Segura-Correa JC, Ortega-Pacheco A, et al. Seroprevalence of pathogenic Leptospira in domiciled and stray dogs from subtropical Mexico. Vet Res Commun. 2025. https://pubmed.ncbi.nlm.nih.gov/41359150/